The "middlemen of medicine" have become obstacles to progress, often perpetuating inefficiencies and exacerbating healthcare's existing problems.

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story PBM reform push heats up Congress is ...

Several accused had formed local peddling gangs, enlisting college students to distribute the drug within youth circles ... then distributed it in Guntur through middlemen A Anil (20) and P Sudhakar ...

Today, Congresswoman Nikki Budzinski (IL-13) hosted a roundtable with independent pharmacists, pharmacy students and faculty ...

Congresswoman Nikki Budzinski (IL-13) will host a roundtable discussion with independent pharmacists on Saturday, November 2, ...

It remains to be seen how well President Joe Biden’s Inflation Reduction Act will actually work in lowering prescription drug ...

PBMs represent insurers in drug transactions, and they decide which medicines will be covered. And, because just three PBMs control access to about 80% of insured patients, they have enormous ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s ...

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...

Analyst reactions to Donald Trump’s election victory were mixed Wednesday, with potential positives including an FTC that is ...